MenuMenuX Close
Home / Awards and Recognitions

Awards & Recognitions

#1 in India’s pharma and biotech sector

Top 10 among all Indian companies, across all sectors/industries

Top 20 globally in Pharma & Biotech sector

Syngene wins Gold for sustainability excellence in healthcare & pharma at the Electronics City Industrial Township Authority awards 2024 -25, Bengaluru

Syngene was recognized as a finalist in the ‘Best Talent Acquisition Team – Corporate sector’ category by LinkedIn

Ranked #1 among India’s top 10 pharma companies in female workforce representation (26% by Fortune India)

Asia Pacific Biologics CMO Excellence Awards 2024

National Convention on Quality Concepts (NCQC) - Excellence Award 2024

Chapter Convention on Quality Concepts (CCQC) - Gold Award – Project on Cost of Poor Quality (COPQ)

Indian Society for Clinical Research (ISCR) - Hall of Fame Award for Medical Writing

Quality Circle Forum of India (QCFI), Bengaluru Chapter - 03 Gold Awards

National Convention on Quality Concepts (NCQC) - Three Excellence Awards

National Six Sigma Competition 2024 - Confederation of Indian Industry (CII) - Platinum Award – 5 Lean Six Sigma Projects

Integrated Supply Chain Management ( ISCM ) Supply Chain Rankings 2025 - 2nd Rank - ‘Pharma Supply Chain Champion’ awards (mid-sized pharma and API firms)

Featured in Business World magazine’s India’s Most Sustainable Companies (IMSC) 2024 list and ranked 91st overall and 9th out of 26 companies in the pharmaceutical sector

41 external awards and recognitions from both national and international platforms, celebrating our achievements in Lean Six Sigma, Kaizen, Process Innovation, Poka-Yoke

ESG Rating Performance

ESG Rating Agency

  • EcoVadis
  • CDP
  • Sustainalytics
  • MSCI
  • DJSI

FY25

  • Silver (91st percentile)
  • Results are awaited
  • 14.7 Low Risk
  • A
  • 76

FY24

  • Silver (86th percentile)
  • B (Water)
    B (Climate Change)
  • 15.6 Low Risk
  • BB
  • 50

FY23

  • Bronze (65th percentile)
  • D (Water)
    C (Climate Change)
  • 12.4 Low Risk
  • BBB
  • N/A

© 2025 Syngene International. All Rights Reserved